法明制药 PHAR
$12.29 −$0.01 (-0.08%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $12.29 0.00%
开盘$12.05
昨收$12.30
当日区间$12.05 – $12.38
成交量9,729
市值$869.86M
市盈率（TTM）37.2
股息率–
PHAR 相关新闻
匹配 Pharming Group 或代码 PHAR 的头条新闻，按最新排序。
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $38 正面
- EXTRAWELL PHAR: FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M.
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $40 负面
- CCORF Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $37
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $41 负面
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $42
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $41 正面
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- Pharming Group (PHAR) Receives a Buy From H.C. Wainwright
暂无评论——快来第一个聊聊 PHAR。
登录后参与讨论。